Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial

BACKGROUND: Replacement of vitamin D (VD) among patients with chronic hepatitis C (CHC) before viral eradication has demonstrated a protective effect on serum markers associated with hepatic fibrogenesis. We therefore hypothesized that VD may facilitate further fibrosis amelioration following curati...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PeerJ
Auteurs principaux: Sriphoosanaphan, Supachaya, Thanapirom, Kessarin, Kerr, Stephen J., Suksawatamnuay, Sirinporn, Thaimai, Panarat, Sittisomwong, Sukanya, Sonsiri, Kanokwan, Srisoonthorn, Nunthiya, Teeratorn, Nicha, Tanpowpong, Natthaporn, Chaopathomkul, Bundit, Treeprasertsuk, Sombat, Poovorawan, Yong, Komolmit, Piyawat
Format: Artigo
Langue:Inglês
Publié: PeerJ Inc. 2021
Sujets:
Clinical Trials
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7879942/
https://ncbi.nlm.nih.gov/pubmed/33614272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.10709
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires